| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $54.7M | +13.8% |
| Cost of Revenue | $13.0M | +12.5% |
| Gross Profit | $41.7M | +14.3% |
| R&D Expense | $656K | -28.4% |
| SG&A Expense | $34.5M | +9.2% |
| Operating Income | $6.6M | +64.2% |
| Pre-tax Income | $7.0M | +72.2% |
| Income Tax | $1.9M | +105.0% |
| Net Income | $5.2M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.1M | +118.1% |
| Accounts Receivable | $23.3M | -3.3% |
| Inventory | $3.7M | -12.1% |
| Current Assets | $44.2M | +16.9% |
| Total Assets | $52.2M | +14.0% |
| Current Liabilities | $7.7M | -4.7% |
| Total Liabilities | $7.7M | -5.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.1M | +589.5% |
| Capital Expenditures | $287K | -82.6% |
| Investing Cash Flow | -$395K | +77.0% |
| Financing Cash Flow | $36K | +109.5% |
| Free Cash Flow | $8.8M | +2736.6% |
| +62.7% |
| EPS (Basic) | $0.60 | +62.2% |
| EPS (Diluted) | $0.58 | +61.1% |
| Stockholders' Equity |
| $44.5M |
| +18.3% |